false
0001604778
0001604778
2025-08-14
2025-08-14
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
August 14, 2025
(Date of earliest event reported)

Qorvo, Inc.
(Exact name of registrant as specified in its charter)
Delaware
|
001-36801 |
46-5288992 |
(State
or Other Jurisdiction of Incorporation)
|
(Commission
File Number)
|
(I.R.S.
Employer Identification No.)
|
7628 Thorndike
Road, Greensboro,
North Carolina 27409-9421
(Address of principal executive offices)
(Zip Code)
(336)
664-1233
Registrant's telephone number, including area code
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ | Written communications pursuant
to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
Common Stock, $0.0001 par value |
|
QRVO |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Item 5.02. Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On August 14, 2025, the Board of Directors (the
“Board”) of Qorvo, Inc. (the “Company”) approved certain arrangements with the Company’s named executive
officers (other than its Chief Executive Officer, Robert A. Bruggeworth) which were the result of a review undertaken by the Company,
together with the assistance of its independent compensation consultant, to determine whether the Company’s existing severance arrangements
with such named executive officers remained aligned with current market practice among the Company’s peers.
The Board approved the entry by the Company
into an Amended and Restated Change in Control Agreement with each named executive (officer other than Mr. Bruggeworth) which
provides for, among other things, the following modifications to the executive’s severance payments and benefits as previously
in effect in the event of a qualifying termination of employment in connection with a change in control of the Company: (i) an
increase in the executive’s cash severance multiple from 1x to 1.5x (other than its Chief Financial Officer, Grant A. Brown, whose multiple did not change), (ii) an increase in the COBRA coverage period from 12 to 18 months and (iii) measurement of
accelerated performance-based equity awards at the greater of target and actual performance (which previously would have been
measured at target).
The Board also approved the adoption of an Executive
Severance Plan under which the Company’s named executive officers (other than Mr. Bruggeworth) would be eligible to receive the
following severance payments and benefits in the event of a qualifying termination of employment other than in connection with a change
in control: (i) a cash severance payment equal to the executive’s base salary plus annualized target bonus opportunity (paid over
12 months), (ii) a pro-rata annual bonus for the year of termination based on actual performance (paid in a lump sum), (iii) COBRA coverage
for 12 months and (iv) one year of continued vesting of outstanding equity awards in exchange for a non-compete.
The receipt of the payments and benefits described
above is subject in all cases to the executive’s execution and non-revocation of a release of claims and compliance with post-employment
restrictive covenants.
The foregoing descriptions do not purport to be
complete and are subject to, and qualified in their entirety by, the full text of such arrangements, copies of which will be attached
as exhibits to the Company’s Quarterly Report on Form 10-Q filed for the quarter ending September 27, 2025.
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Qorvo, Inc. |
|
|
|
|
By: |
/s/ Grant A. Brown |
|
|
Grant
A. Brown
|
|
|
Senior
Vice President and Chief Financial Officer
|
Date: August 15, 2025